1. Home
  2. MBAV vs ABSI Comparison

MBAV vs ABSI Comparison

Compare MBAV & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBAV
  • ABSI
  • Stock Information
  • Founded
  • MBAV 2024
  • ABSI 2011
  • Country
  • MBAV United States
  • ABSI United States
  • Employees
  • MBAV N/A
  • ABSI N/A
  • Industry
  • MBAV
  • ABSI Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBAV
  • ABSI Health Care
  • Exchange
  • MBAV NYSE
  • ABSI Nasdaq
  • Market Cap
  • MBAV 413.3M
  • ABSI 338.0M
  • IPO Year
  • MBAV 2024
  • ABSI 2021
  • Fundamental
  • Price
  • MBAV $13.53
  • ABSI $2.79
  • Analyst Decision
  • MBAV
  • ABSI Strong Buy
  • Analyst Count
  • MBAV 0
  • ABSI 5
  • Target Price
  • MBAV N/A
  • ABSI $8.40
  • AVG Volume (30 Days)
  • MBAV 702.5K
  • ABSI 2.9M
  • Earning Date
  • MBAV 01-01-0001
  • ABSI 08-13-2025
  • Dividend Yield
  • MBAV N/A
  • ABSI N/A
  • EPS Growth
  • MBAV N/A
  • ABSI N/A
  • EPS
  • MBAV 0.28
  • ABSI N/A
  • Revenue
  • MBAV N/A
  • ABSI $4,815,000.00
  • Revenue This Year
  • MBAV N/A
  • ABSI $81.76
  • Revenue Next Year
  • MBAV N/A
  • ABSI $287.79
  • P/E Ratio
  • MBAV $48.81
  • ABSI N/A
  • Revenue Growth
  • MBAV N/A
  • ABSI N/A
  • 52 Week Low
  • MBAV $9.97
  • ABSI $2.01
  • 52 Week High
  • MBAV $13.73
  • ABSI $6.33
  • Technical
  • Relative Strength Index (RSI)
  • MBAV N/A
  • ABSI 47.46
  • Support Level
  • MBAV N/A
  • ABSI $2.65
  • Resistance Level
  • MBAV N/A
  • ABSI $2.87
  • Average True Range (ATR)
  • MBAV 0.00
  • ABSI 0.19
  • MACD
  • MBAV 0.00
  • ABSI -0.01
  • Stochastic Oscillator
  • MBAV 0.00
  • ABSI 24.03

About MBAV M3-BRIGADE ACQUISITION V CORP

M3-Brigade Acquisition V Corp is a blank check company.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Share on Social Networks: